Literature DB >> 11667528

Protection of the Hydroxyphosphinyl Function of Phosphinic Dipeptides by Adamantyl. Application to the Solid-Phase Synthesis of Phosphinic Peptides.

Athanasios Yiotakis1, Stamatia Vassiliou, Jirí Jirácek, Vincent Dive.   

Abstract

To develop solid-phase synthesis of phosphinic peptides, different FmocXaaPsi{PO(OAd)CH(2)}XaaOH building blocks have been prepared, where Fmoc is (fluorenylmethoxy)carbonyl. In this respect, the protection of the hydroxyphosphinyl function in these phosphinic dipeptides by the adamantyl group turns out to be convenient. The phosphinic adamantyl esters are completely stable in basic conditions and can be removed under relatively mild acidic conditions. Using these building blocks, despite the bulkiness of the adamantyl group, no particular problem of coupling was observed during the solid-phase synthesis of phosphinic peptides by the Fmoc strategy. The developed methodology is of particular interest to facilitate the development of potent inhibitors of zinc-metalloproteases.

Entities:  

Year:  1996        PMID: 11667528     DOI: 10.1021/jo9603439

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  15 in total

1.  Triple-helical transition state analogues: a new class of selective matrix metalloproteinase inhibitors.

Authors:  Janelle Lauer-Fields; Keith Brew; John K Whitehead; Shunzi Li; Robert P Hammer; Gregg B Fields
Journal:  J Am Chem Soc       Date:  2007-08-02       Impact factor: 15.419

2.  RXP 407, a phosphinic peptide, is a potent inhibitor of angiotensin I converting enzyme able to differentiate between its two active sites.

Authors:  V Dive; J Cotton; A Yiotakis; A Michaud; S Vassiliou; J Jiracek; G Vazeux; M T Chauvet; P Cuniasse; P Corvol
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-13       Impact factor: 11.205

3.  Efficient synthesis of Fmoc-protected phosphinic pseudodipeptides: Building blocks for the synthesis of matrix metalloproteinase inhibitors.

Authors:  Manishabrata Bhowmick; Ravinder R Sappidi; Gregg B Fields; Salvatore D Lepore
Journal:  Biopolymers       Date:  2011       Impact factor: 2.505

4.  Phosphinic peptides, the first potent inhibitors of astacin, behave as extremely slow-binding inhibitors.

Authors:  I Yiallouros; S Vassiliou; A Yiotakis; R Zwilling; W Stöcker; V Dive
Journal:  Biochem J       Date:  1998-04-15       Impact factor: 3.857

5.  Synthesis of P,N-heterocycles from omega-amino-H-phosphinates: conformationally restricted alpha-amino acid analogs.

Authors:  Clémence Queffelec; Patrice Ribière; Jean-Luc Montchamp
Journal:  J Org Chem       Date:  2008-10-15       Impact factor: 4.354

6.  Synthesis and in Vitro and in Vivo Evaluation of MMP-12 Selective Optical Probes.

Authors:  Thomas Bordenave; Marion Helle; Fabrice Beau; Dimitris Georgiadis; Livia Tepshi; Mylène Bernes; Yunpeng Ye; Laure Levenez; Enora Poquet; Hervé Nozach; Mahmoud Razavian; Jakub Toczek; Enrico A Stura; Vincent Dive; Mehran M Sadeghi; Laurent Devel
Journal:  Bioconjug Chem       Date:  2016-09-14       Impact factor: 4.774

7.  Phosphinic acid-based inhibitors of tubulin polyglutamylases.

Authors:  Yanjie Liu; Christopher P Garnham; Antonina Roll-Mecak; Martin E Tanner
Journal:  Bioorg Med Chem Lett       Date:  2013-05-30       Impact factor: 2.823

8.  A common single nucleotide polymorphism in endoplasmic reticulum aminopeptidase 2 induces a specificity switch that leads to altered antigen processing.

Authors:  Irini Evnouchidou; James Birtley; Sergey Seregin; Athanasios Papakyriakou; Efthalia Zervoudi; Martina Samiotaki; George Panayotou; Petros Giastas; Olivia Petrakis; Dimitris Georgiadis; Andrea Amalfitano; Emmanuel Saridakis; Irene M Mavridis; Efstratios Stratikos
Journal:  J Immunol       Date:  2012-07-25       Impact factor: 5.422

9.  Synthesis of Fmoc-Gly-Ile Phosphinic Pseudodipeptide: Residue Specific Conditions for Construction of Matrix Metalloproteinase Inhibitor Building Blocks.

Authors:  Manishabrata Bhowmick; Gregg B Fields
Journal:  Int J Pept Res Ther       Date:  2012-12       Impact factor: 1.931

10.  Rationally designed inhibitor targeting antigen-trimming aminopeptidases enhances antigen presentation and cytotoxic T-cell responses.

Authors:  Efthalia Zervoudi; Emmanuel Saridakis; James R Birtley; Sergey S Seregin; Emma Reeves; Paraskevi Kokkala; Yasser A Aldhamen; Andrea Amalfitano; Irene M Mavridis; Edward James; Dimitris Georgiadis; Efstratios Stratikos
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-18       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.